Related content

Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil

By Goeldner Isabela  

Clinical Rheumatology, Vol. 30, Iss. 7, 2011-07 ,pp. : 975-980

Springer Publishing Company

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite

Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis

By Kudo-Tanaka Eriko   Ohshima Shiro   Ishii Masaru   Mima Toru   Matsushita Masato   Azuma Naoto   Harada Yoshinori   Katada Yoshinori   Ikeue Hitomi   Umeshita-Sasai Mitsuko   Miyatake Kunio   Saeki Yukihiko  

Clinical Rheumatology, Vol. 26, Iss. 10, 2007-10 ,pp. : 1627-1633

Springer Publishing Company

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis

By Guler H.   Turhanoglu A. D.   Ozer B.   Ozer C.   Balci A.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 337-342

Informa Healthcare

Access to resources Recommend Favorite